Navigation Links
Variation in women's X chromosomes may explain differences among individuals, between sexes

.

Originally, scientists had assumed that the inactivation process resulted in complete silencing of the genes on the second X chromosome, Willard said, in order to leave both sexes with the same activity level, or dosage, of the genes encoded by the X chromosome. Scientists had also implicitly assumed that the X chromosomes in all women would be identical.

Earlier work of Willard and others shattered the first assumption, when, in the late 1980s, the first evidence came to light that some portion of the genes on the second X chromosome in women remained active.

The new work extends that earlier finding to the full set of X-linked genes and also further reveals that individual women exhibit extensive differences among them with respect to X inactivation, Willard said.

In their study, the researchers isolated cell lines from each of 40 women. They then measured the activity level of each of 471 genes to determine whether the second copy was turned on or off.

Overall, about 15 percent of genes on the second X chromosome escape inactivation to some degree, they found. The proportion of genes that remain active differs dramatically among regions of the X chromosome, they reported.

Furthermore, in some women but not others, an additional 10 percent of X-linked genes demonstrate variable patterns of inactivation and different levels of activity in the "silenced" X chromosomes, the team reported.

"The findings suggest a remarkable and previously unsuspected degree of expression heterogeneity among females in the population," Willard said. Further work is required to explore potential consequences of that variation, he added.

However, the large number of genes that escape inactivation and their concentration in certain portions of the X chromosome has immediate implications for counseling the one in every 650 individuals born with X chromosome abnormalities, Willard said. The expected severity of symptoms assoc
'"/>

Source:Duke University Medical Center


Page: 1 2 3

Related biology news :

1. Genetic Variation Visualization - From EMBL
2. Variation in HIVs ability to disable host defenses contributes to rapid evolution
3. Variation in bitter-taste receptor gene increases risk for alcoholism
4. Variations in detoxifying genes linked to Lou Gehrigs disease
5. Of mice and mens (and womens) contraceptives
6. Heavy smoking cuts womens chance of pregnancy -- even with donated oocytes
7. Scientists analyze chromosomes 2 and 4
8. Mouse to man: The story of chromosomes
9. Researchers use multiphoton microscopy to watch chromosomes in action
10. Short chromosomes put cancer cells in forced rest
11. Researchers attach genes to minichromosomes in maize
Post Your Comments:
(Date:2/12/2015)...   MedNet Solutions , a global life ... systems, has recently bolstered its iMedNet™ ... iMedNet as the eClinical solution of ... consultants.  Building on the Program,s existing benefits (including ... co-marketing opportunities), MedNet,s new and improved program provides ...
(Date:2/11/2015)... 2015 According to ... Market by Product (Cards and Readers, Biometrics, Controllers, Management ... Industrial, Healthcare, Education) and By Geography - Global Forecast and Analysis ... Access Control Market is expected to reach ... CAGR of 10.6% between 2014 and 2020. ...
(Date:2/9/2015)... Texas , Feb. 9, 2015  Lintec of ... fabrication methods for carbon nanotube (CNT) macrostructures, including sheets, ... at Dallas (UTD). Leveraging the vast industrial ... Tokyo, Japan , Lintec of America is ... Richardson, TX , focusing on scaling up ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... by researchers at Hasbro Childrens Hospital, the pediatric division ... York, offers new insight into the role that the ... disease. The cystic fibrosis transmembrane conductance regulator (CFTR) ... Mutations of this protein are associated with cystic fibrosis ...
... which tend to involve localized changes in sea surface ... than the more uniform patterns of global warming, a ... debate over the effect of global warming on hurricanes, ... more favorable environment for hurricane development and intensification. However, ...
... Viejo, California) Ossur, an emerging leader in the ... of integration, is pleased to announce that the Journal ... two year cervical collar study performed by the Mayo ... Interface Pressure from Four Cervical Collars, finds that Ossurs ...
Cached Biology News:Study uncovers clues to cystic fibrosis gene dysfunction and gastrointestinal disease 2Climate's remote control on hurricanes 2Mayo Clinic study: Ossur's collars superior in immobilization and reduction of pressure 2
(Date:2/27/2015)... Mass. , Feb. 27, 2015 ... of the NCATS rare-diseases portfolio " in ... a new financing technique to reduce the risk ... diseases and potentially unlock new levels of funding ... The product of a unique collaboration between scientists ...
(Date:2/27/2015)... 27, 2015  Pfenex Inc. (NYSE MKT: PFNX), a ... therapeutics, today announced that it will be presenting at ... March 2 nd at 3pm PST. Patrick Lucy, chief ... discussing the current state of the biosimilar industry landscape ... For more information on CALBIO 2015 and ...
(Date:2/26/2015)... 26, 2015 S&P Capital IQ (MHFI) announced ... coverage on MabVax Therapeutics Holdings Inc . ... stage biotechnology company focused on the development of vaccine ... the treatment of cancer. MabVax has discovered a pipeline ... immune responses generated by patients who have been immunized ...
(Date:2/26/2015)... 2015   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... Chief Executive Officer of Regulus, will present a company ... Annual Healthcare Conference on Wednesday, March 4, 2015 at ... the Boston Marriott Copley Place.  The ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3
... differences among countries. This is what medical researchers ... from biobanks in their research. For one thing, ... international studies. In the latest issue of Nature ... (CBE), together with leading biobank researchers, put forward a ...
... of disease is often critical to how successful treatment can ... is a hot research field, where every small step is ... issue of Molecular & Cellular Proteomics, Uppsala University researchers describe ... Proteins build up the bodys cells and tissues, and our ...
... Washington DC*-- Key components of a new approach to ... Friday as part of a twelve-day, low-Earth orbit experiment ... prelude future journeys to Mars. , The new approach ... pregnancy test kits. The so-called immunoassays are embodied in ...
Cached Biology Technology:Long-awaited international ethical guidelines for biobank researchers 2Life on Mars 'pregnancy test' successfully launched 2